Production of nerve growth factor by β-amyloid-stimulated astrocytes induces p75NTR-dependent tau hyperphosphorylation in cultured hippocampal neurons

Journal of Neuroscience Research

Volumn 84, Issue 5, 2006, Pages 1098-1106

  Sáez, Estefanía T ^a   Pehar, Mariana ^b   Vargas, Marcelo R ^b   Barbeito, Luis ^b   Maccioni, Ricardo B ^a,c  

^a UNIVERSITY OF CHILE   (Chile)

^b INSTITUTO DE INVESTIGACIONES BIOLÓGICAS CLEMENTE ESTABLE   (Uruguay)

^c Millennium Institute CBB   (Chile)

Author keywords

Alzheimer's disease; Apoptosis; Astrocytes; NGF; p75 neurotrophin receptor

Indexed keywords

AMYLOID BETA PROTEIN[25-35]; CASPASE INHIBITOR; NERVE GROWTH FACTOR; NEUROTROPHIN RECEPTOR; NITRIC OXIDE; PROTEIN P75; TAU PROTEIN;

ANIMAL CELL; ARTICLE; ASTROCYTE; CELL DEATH; CELL SURVIVAL; CONTROLLED STUDY; EMBRYO CELL; HIPPOCAMPUS; MOUSE; NERVE CELL; NERVE CELL CULTURE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT;

AMYLOID BETA-PEPTIDES; AMYLOID BETA-PROTEIN; ANIMALS; ANIMALS, NEWBORN; ASTROCYTES; BLOTTING, WESTERN; CELL SURVIVAL; CULTURE MEDIA, CONDITIONED; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; ENZYME INHIBITORS; GENE EXPRESSION; HIPPOCAMPUS; NERVE GROWTH FACTOR; NEURONS; PEPTIDE FRAGMENTS; PHOSPHORYLATION; RATS; RECEPTORS, NERVE GROWTH FACTOR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TAU PROTEINS; TIME FACTORS;

EID: 33749534896     PISSN: 03604012     EISSN: 10974547     Source Type: Journal    
DOI: 10.1002/jnr.20996     Document Type: Article

References (72)

1. Akama KT, Van Eldik LJ. 2000. Beta-amyloid stimulation of inducible nitric-oxide synthase in astrocytes is interleukin-1beta- and tumor necrosis factor-alpha (TNFalpha)-dependent, and involves a TNFalpha receptor-associated factor- and NFkappaB-inducing kinase-dependent signaling mechanism. J Biol Chem 275:7918-7924.
2. Alvarez A, Toro R, Caceres A, Maccioni RB. 1999. Inhibition of tau phosphorylating protein kinase cdk5 prevents beta-amyloid-induced neuronal death. FEBS Lett 459:421-426.
3. Alvarez A, Muñoz JP, Maccioni RB. 2001. A Cdk5-p35 stable complex is involved in the beta-amyloid-induced deregulation of Cdk5 activity in hippocampal neurons. Exp Cell Res 264:266-274.
4. Bach JH, Chae HS, Rah JC, Lee MW, Park CH, Choi SH, Choi JK, Lee SH, Kim YS, Kim KY, Lee WB, Suh YH, Kim SS. 2001. C-terminal fragment of amyloid precursor protein induces astrocytosis. J Neurochem 78:109-120.
5. Bales KR, Du Y, Dodel RC, Yan GM, Hamilton-Byrd E, Paul SM. 1998. The NF-kappaB/Rel family of proteins mediates Abeta-induced neurotoxicity and glial activation. Brain Res Mol Brain Res 57:63-72.
6. Banker G, Cowan W. 1977. Rat hippocampal neurons in dispersed cell culture. Brain Res 126:397-342.
7. Barrett GL. 2000. The p75 neurotrophin receptor and neuronal apoptosis. Prog Neurobiol 61:205-229.
8. Boissiere F, Faucheux B, Ruberg M, Agid Y, Hirsch EC. 1997. Decreased TrkA gene expression in cholinergic neurons of the striatum and basal forebrain of patients with Alzheimer's disease. Exp Neurol 145:245-252.
9. Brandt R, Leger J, Lee G. 1995. Interaction of tau with the neuronal plasma membrane mediated by tau's amino-terminal projection domain. J Cell Biol 131:1327-1340.
10. Brunden KR, Frederickson RCA. 2002. Activated neuroglia in Alzheimer's disease. In: De Vellis JS, editor. Neuroglia in the aging brain. Totowa, NJ: Humana Press, p 365-374.
11. Buck CR, Martinez HJ, Chao MV, Black IB. 1988. Differential expression of the nerve growth factor receptor gene in multiple brain areas. Brain Res Dev Brain Res 44:259-268.
12. Bui NT, Konig HG, Culmsee C, Bauerbach E, Poppe M, Krieglstein J, Prehn JH. 2002. p75 Neurotrophin receptor is required for constitutive and NGF-induced survival signalling in PC12 cells and rat hippocampal neurones. J Neurochem 81:594-605.
13. Cassina P, Pehar M, Vargas MR, Castellanos R, Barbeito AG, Estevez AG, Thompson JA, Beckman JS, Barbeito L. 2005. Astrocyte activation by fibroblast growth factor-1 and motor neuron apoptosis: implications for amyotrophic lateral sclerosis. J Neurochem 93:38-46.
14. Chao MV. 2003. Neurotrophins and their receptors: a convergence point form many signalling pathways. Nat Rev Neurosci 4:299-309.
15. NTR molecular switch activates amyloid beta-peptide generation during aging. Biochem J 391:59-67.
16. Counts SE, Nadeem M, Wuu J, Ginsberg SD, Saragovi HU, Mufson EJ. 2004. Reduction of cortical TrkA but not p75(NTR) protein in early-stage Alzheimer's disease. Ann Neurol 56:520-531.
17. Cross D, Vial C, Maccioni RB. 1993. A tau-like protein interacts with stress fibers and microtubules in human and rodent cultured cell lines. J Cell Sci 105:51-60.
18. Cross D, Tapia L, Garrido J, Maccioni RB. 1996. Tau-like proteins associated with centrosomes in cultured cells. Exp Cell Res 229:378-387.
19. Crutcher KA, Scott SA, Liang S, Everson WV, Weingartner J. 1993. Detection of NGF-like activity in human brain tissue: increased levels in Alzheimer's disease. J Neurosci 13:2540-2550.
20. Culmsee C, Gerling N, Lehmann M, Nikolova-Karakashian M, Prehn JH, Mattson MP, Krieglstein J. 2002. Nerve growth factor survival signaling in cultured hippocampal neurons is mediated through TrkA and requires the common neurotrophin receptor P75. Neuroscience 115:1089-1108.
21. Duffy PE, Rapport M, Graf L. 1980. Glial fibrillary acidic protein and Alzheimer-type senile dementia. Neurology 30:778-782.
22. Ernfors P, Lindefors N, Chan-Palay V, Persson H. 1990. Cholinergic neurons of the nucleus basalis express elevated levels of nerve growth factor receptor mRNA in senile dementia of the Alzheimer's type. Dementia 1:138-145.
23. Fahnestock M, Scott SA, Jette N, Weingartner JA, Crutcher KA. 1996. Nerve growth factor mRNA and protein levels measured in the same tissue from normal and Alzheimer's disease parietal cortex. Brain Res Mol Brain Res 42:175-178.
24. Fahnestock M, Michalski B, Xu B, Conghlim M. 2001. The precursor pro-nerve growth factor is the predominant form of nerve growth factor in brain and is increased in Alzheimer's disease. Mol Cel Neurosci 18:210-220.
25. Fischer W, Wictorin K, Bjorklund A, Williams LR, Varon S, Gage FH. 1987. Amelioration of cholinergic neuron atrophy and spatial memory impairment in aged rats by nerve growth factor. Nature 329:65-68.
26. Frederickson RC. 1992. Astroglia in Alzheimer's disease. Neurobiol Aging 13:239-253.
27. Friedman WJ. 2000. Neurotrophins induce death of hippocampal neurons via the p75 receptor. J Neurosci 20:6340-6346.
28. Galve-Roperh I, Malpartida JM, Haro A, Brachet P, Diaz-Laviada I. 1997. Regulation of nerve growth factor secretion and mRNA expression by bacterial lipopolysaccharide in primary cultures of rat astrocytes. J Neurosci Res 49:569-575.
29. Giasson BI, Ischiroupulos H, Lee VM, Trojanowsky JQ. 2002. The relationship between oxidative/nitrative stress and pathological inclusions in Alzheimer's and Parkinson's disease. Free Rad Biol Med 32:1264-1275.
30. Ginsberg SD, Che S, Wuu J, Counts SE, Mufson EJ. 2006. Down regulation of trk but not p75 gene expression in single cholinergic basal forebrain neurons mark the progression of Alzheimer's disease. J Neurochem 97:475-487.
31. Goedert M, Fine A, Dawbarn D, Wilcock GK, Chao MV. 1989. Nerve growth factor receptor mRNA distribution in human brain: normal levels in basal forebrain in Alzheimer's disease. Brain Res Mol Brain Res 5:1-7.
32. Hensley K, Maidt ML, Yu Z, Sang H, Markesbery WR, Floyd RA. 1998. Electrochemical analysis of protein nitrotyrosine and dityrosine in the Alzheimer brain indicates region-specific accumulation. J Neurosci 18:8126-8132.
33. Hock C, Heese K, Muller-Spahn F, Hulette C, Rosenberg C, Otten U. 1998. Decreased trkA neurotrophin receptor expression in the parietal cortex of patients with Alzheimer's disease. Neurosci Lett 241:151-154.
34. Hock C, Heese K, Hulette C, Rosenberg C, Otten U. 2000. Region-specific neurotrophin imbalances in Alzheimer disease: decreased levels of brain-derived neurotrophic factor and increased levels of nerve growth factor in hippocampus and cortical areas. Arch Neurol 57:846-851.
35. Hu J, Akama KT, Krafft GA, Chromy BA, Van Eldik LJ. 1998. Amyloid-beta peptide activates cultured astrocytes: morphological alterations, cytokine induction and nitric oxide release. Brain Res 785:195-206.
36. Hu XY, Zhang HY, Qin S, Xu H, Swaab DF, Zhou JN. 2002. Increased p75 (NTR) expression in hippocampal neurons containing hyperphosphorylated tau in Alzheimer patients. Exp Neurol 178:104-111.
37. Johnson GV, Stoothoff WH. 2004. Tau phosphorylation in neuronal cell function and dysfunction. J Cell Sci 117:5721-5729.
38. Kiss J, McGovern J, Patel AJ. 1988. Immunohistochemical localization of cells containing nerve growth factor receptors in the different regions of the adult rat forebrain. Neuroscience 27:731-748.
39. Krenz NR, Weaver LC. 2000. Nerve growth factor in glia and inflammatory cells of the injured rat spinal cord. J Neurochem 74:730-739.
40. Levi-Montalcini R, Skaper SD, Dal Toso R, Petrelli L, Leon A. 1996. Nerve growth factor: from neurotrophin to neurokine. Trends Neurosci 19:514-520.
41. Loo DT, Copani A, Pike CJ, Whittemore ER, Cotman CW. 1993. Apoptosis is induced by beta-amyloid in cultured central nervous system neurons. Proc Natl Acad Sci U S A 90:7951-7959.
42. Lu B, Buck CR, Dreyfus CF, Black IB. 1989. Expression of NGF and NGF receptor mRNAs in the developing brain: evidence for local delivery and action of NGF. Exp Neurol 104:191-199.
43. Maccioni RB, Muñoz JP, Barbeito L. 2001. The molecular bases of Alzheimer's disease and other neurodegenerative disorders. Arch Med Res 32:367-381.
44. Majdan M, Miller F. 1999. Neuronal life and death decisions: functional antagonism between the Trk and p75 neurotrophin receptors. Int J Dev Neurosci 17:153-161.
45. Mancardi GL, Liwnicz BH, Mandybur TI. 1983. Fibrous astrocytes in Alzheimer's disease and senile dementia of Alzheimer's type. Acta Neuropathol 61:76-80.
46. McGeer EG, McGeer PL. 2003. Inflammatory processes in Alzheimer's disease. Prog Neuropsychopharmacol Biol Psychiatry 27:741-749.
47. Miller FD, Kaplan DR. 2001. Neurotrophin signalling pathways regulating neuronal apoptosis. Cell Mol Life Sci 58:1045-1053.
48. Mufson EJ, Kordower JH. 1992. Cortical neurons express nerve growth factor receptors in advanced age and Alzheimer disease. Proc Natl Acad Sci U S A 89:569-573.
49. Mufson EJ, Lavine N, Jaffar S, Kordower JH, Quirion R, Saragovi HU. 1997. Reduction in p140-TrkA receptor protein within the nucleus basalis and cortex in Alzheimer's disease. Exp Neurol 146:91-103.
50. Nathan C, Calingasan N, Nezezov J, Ding A, Lucia MS, La Perle K, Fuertes M, Lin M, Ehrt S, Kwon NS, Chen J, Vodovotz Y, Kipiani K, Beal MF. 2005. Protection from Alzheimer's disease in the mouse by genetic ablation of inducible nitric oxide synthase. J Exp Med 202:1163-1169.
51. NTR-live or let die. Curr Opin Neurobiol 15:49-57.
52. NTR. Am J Pathol 166:533-543.
53. Pehar M, Cassina P, Vargas MR, Castellanos R, Viera L, Beckman J, Estévez A, Barbeito L. 2004. Astrocytic production of nerve growth factor in motor neuron apoptosis: implication for amyotrophic lateral sclerosis. J Neurochem 89:464-473.
54. Peng S, Wuu J, Mufson EJ, Fahnestock M. 2004. Increased proNGF levels in subjects with mild cognitive impairment and mild Alzheimer disease. J Neuropathol Exp Neurol 63:641-649.
55. Pike CJ, Cummings BJ, Monzavi R, Cotman CW. 1994. Beta-amyloid-induced changes in cultured astrocytes parallel reactive astrocytosis associated with senile plaques in Alzheimer's disease. Neuroscience 63:517-531.
56. Pike CJ, Ramezan-Arab N, Cotman CW. 1997. Beta-amyloid neurotoxicity in vitro: evidence of oxidative stress but not protection by antioxidants. J Neurochem 69:1601-1611.
57. Rabizadeh S, Bredesen DE. 1994. Is p75NGFR involved in developmental neural cell death? Dev Neurosci 16:207-211.
58. Rappaport SI. 2003. Coupled reductions in brain oxidative phosphorylation and synaptic function can be quantified and staged in the course of Alzheimer's disease. Neurotox Res 5:385-398.
59. Roux PP, Colicos MA, Barker PA, Kennedy TE. 1999. p75 neurotrophin receptor expression is induced in apoptotic neurons after seizure. J. Neurosci 19:6887-6896.
60. Sáez TE, Pehar M, Vargas M, Barbeito L, Maccioni RB. 2004. Astrocytic nitric oxide triggers tau hyperphosphorylation in hippocampal neurons. In Vivo 18:275-280.
61. Saneto RP, De Vellis J. 1987. Neuronal and glial cells: cell culture of the central nervous system. In: Turner AJ, Brachelard HS, editors. Neurochemistry: a practical approach. Washington, DC: IRL Press, p 27-63.
62. Savaskan E, Muller-Spahn F, Olivieri G, Bruttel S, Otten U, Rosenberg C, Hulette C, Hock C. 2000. Alterations in trk A, trk B and trk C receptor immunoreactivities in parietal cortex and cerebellum in Alzheimer's disease. Eur Neurol 44:172-180.
63. Schechter R, Yen SH, Terry RD. 1981. Fibrous astrocytes in senile dementia of the Alzheimer type. J Neuropathol Exp Neurol 40:95-101.
64. Scott SA, Mufson EJ, Weingartner JA, Skau KA, Crutcher KA. 1995. Nerve growth factor in Alzheimer's disease: increased levels throughout the brain coupled with declines in nucleus basalis. J Neurosci 15:6213-6221.
65. Smith MA, Richey Harris PL, Sayre LM, Beckman JS, Perry G. 1997. Widespread peroxinitrite-mediated damage in Alzheimer's disease. J Neurosci 17:2653-2657.
66. Snider WD. 1994. Functions of the neurotrophins during nervous system development: what the knockouts are teaching us. Cell 77:627-638.
67. Troy CM, Friedman JE, Friedman WJ. 2002. Mechanisms of p75-mediated death of hippocampal neurons. Role of caspases. J Biol Chem 277:34295-34302.
68. Tuszynski MH, Thal L, Pay M, Salmon DP, U HS, Bakay R, Patel P, Blesch A, Vahlsing HL, Ho G, Tong G, Potkin SG, Fallon J, Hansen L, Mufson EJ, Kordower JH, Gall C, Conner J. 2005. A phase 1 clinical trial of nerve growth factor gene therapy for Alzheimer disease. Nat Med 11:551-555.
69. Tuszynski MH, U HS, Amaral DG, Gage FH. 1990. Nerve growth factor infusion in the primate brain reduces lesion-induced cholinergic neuronal degeneration. J Neurosci 10:3604-3614.
70. Walker DG, Beach TG. 2002. Microglial and astrocytic reactions in Alzheimer's disease. In: De Vellis JS, editor. Neuroglia in the aging brain. Totowa, NJ: Humana Press, p 339-363.
71. Yankner BA, Duffy LK, Kirschner DA. 1990. Neurotrophic and neurotoxic effects of amyloid beta protein: reversal by tachykinin neuropeptides. Science 250:279-282.
72. Yoshida K, Gage FH. 1991. Fibroblast growth factors stimulate nerve growth factor synthesis and secretion by astrocytes. Brain Res 538:118-126.